Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial항레트로바이러스 요법(REALITY)을 시작하는 아프리카의 심각한 면역 저하 HIV 감염 개인의 사망률에 대한 즉시 사용 가능한 보충 식품의 효과: 공개, 병렬 그룹, 무작위 대조 시험Article Published on 2018-04-102022-09-06 Journal: The Lancet. HIV [Category] Communicable Disease, [키워드] 1:1 95% CI adverse event adverse events age analysed anti-infection Antiretroviral therapy ART assigned block size BMI body-mass body-mass index both groups CD4 cell Cell changes in children clinic visit Clinic visits computer-generated database Department development died Dispensing Effect eight Eligible participants Evidence evidence of finding funding global health GRADE greater hazard ratio high risk HIV infection hospital hypothesise Immunocompromised in both group individual individuals infected individuals infections Intention intention to treat Interaction ISRCTN ISRCTN registry Kenya log-rank Medical Research Council medication micronutrients Mortality no evidence of nutritional status Older Open-label outcome parallel-group participant Participants peanut per day Policy present Primary outcome Prophylaxis raltegravir randomisation randomised controlled trial Randomly ready-to-use therapeutic food reducing Registered reported Safety secondary Secondary outcomes Serious Adverse Event Serious Adverse Events significantly stratified sub-Saharan Africa Symptom Trial Uganda vital status weight weight gain Wellcome Trust would increase Z score Zimbabwe [DOI] 10.1016/S2352-3018(18)30038-9 PMC 바로가기 [Article Type] Article
Hepatitis B in Moroccan-Dutch: a quantitative study into determinants of screening participationResearch Article Published on 2018-03-292023-05-24 Journal: BMC Medicine [Category] B형 간염, Fulltext, [키워드] determinants hepatitis B Intention Moroccans Netherlands Random forest Screening [DOI] 10.1186/s12916-018-1034-6 PMC 바로가기 [Article Type] Research Article
Economic incentives for HIV testing by adolescents in Zimbabwe: a randomised controlled trial짐바브웨 청소년의 HIV 검사에 대한 경제적 인센티브: 무작위 대조 시험Article Published on 2017-11-202022-09-06 Journal: The Lancet. HIV [Category] Communicable Disease, [키워드] 95% CI adjusted odds ratio Adults adverse event adverse events African analysis Analysis Antiretroviral therapy assigned assistant blinded Care Caregivers children clinical Community Consent Controlled trial Coverage Effect eligible enrolled enrolment finding fixed funding group had no health-care HIV HIV infection HIV testing household Households Intention intention to treat investigated Local Logistic regression much lower not blinded number of children Older outcome Pan Pan African Clinical Trials Registry participant Prevalence prevention service Primary outcome proportion provided random effect randomised controlled trial Randomly receive Registered registry repeated reported Research statistician tested Trial Wellcome Trust Zimbabwe [DOI] 10.1016/S2352-3018(17)30176-5 PMC 바로가기 [Article Type] Article
Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents, and young adults (BREATHER): a randomised, open-label, non-inferiority, phase 2/3 trialHIV에 감염된 어린이, 청소년 및 젊은 성인(BREATHER)에 대한 주말 휴무 에파비렌즈 기반 항레트로바이러스 요법: 무작위, 공개, 비열등성, 2/3상 시험Articles Published on 2016-06-202022-09-06 Journal: The Lancet. HIV [Category] Communicable Disease, [키워드] 1:1 abortion adherent adverse event African age Antiretroviral therapy ART assigned block BREATHER CD4 cell Cell children clinician computer-generated country CTA Dizziness drug efavirenz eligible participant Eligible participants EudraCT European European Commission event finding FIVE France funding grade 3 gynaecomastia headache HIV-1 ideation inferiority inhibitors Intention intention to treat IQR ISRCTN Kaplan-Meier method less life Lipodystrophy list median median age Medical Research Council men neutropenia non-inferiority non-inferiority margin non-inferiority trial nucleoside occurred offer Open-label participant Patient phase 2/3 trial Primary outcome proportion raised randomisation randomisation list randomised Randomly reached Registered reverse transcriptase RNA safety profile Seven shown spontaneous abortion stratified Suicidal ideation Syncope technology Technology assessment the Kaplan-Meier method therapy Toxicity transaminases transcriptase Trial Viral Viral load virological suppression was done web service [DOI] 10.1016/S2352-3018(16)30054-6 PMC 바로가기 [Article Type] Articles
Negative attitude and low intention to vaccinate universally against varicella among public health professionals and parents in the Netherlands: two internet surveysResearch Article Published on 2016-03-152023-05-23 Journal: BMC Infectious Diseases [Category] Fulltext, 두창, 수두, 홍역, [키워드] Chickenpox Epidemiology Intention vaccination varicella Varicella zoster virus [DOI] 10.1186/s12879-016-1442-1 PMC 바로가기 [Article Type] Research Article
Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial아바카비르, 지도부딘 또는 스타부딘을 아프리카 HIV 감염 소아용 정제로 사용(CHAPAS-3): 공개 라벨, 병렬 그룹, 무작위 대조 시험Articles Published on 2016-02-012022-09-06 Journal: The Lancet. Infectious Diseases [Category] Communicable Disease, [키워드] abacavir adverse event adverse events African analysed Antiretroviral therapy ART children clinical database Developing drugs dual efavirenz enrolled European finding Follow-up funding groups hazard ratio hypersensitivity hypersensitivity reactions immunological inhibitor Intention intention to treat ISRCTN registry Laboratory lamivudine less Lipodystrophy median median age nevirapine nucleoside occurred Open-label parallel-group partnership primary endpoint randomisation randomised controlled trial Randomised trial Registered responses stavudine suppression Tablet Toxicity Treatment Trial Uganda Viral Viral load Virological were excluded WHO zidovudine [DOI] 10.1016/S1473-3099(15)00319-9 PMC 바로가기 [Article Type] Articles
Protease inhibitor monotherapy for long-term management of HIV infection: a randomised, controlled, open-label, non-inferiority trialHIV 감염의 장기 관리를 위한 프로테아제 억제제 단독 요법: 무작위, 대조, 공개, 비열등성 시험Articles Published on 2015-09-142022-09-06 Journal: The Lancet. HIV [Category] Communicable Disease, [키워드] 1:1 adverse event age Antiretroviral therapy ART baseline benefit block CD4 Cell Clinical management Clinical outcome clinical risk Combination combination treatment computer-generated Controlled darunavir defined drug drug resistance enrolled finding Frequency funding Genetic GRADE grade 3 HIV HIV infection inferiority inhibitor Intention intention to treat international standard Kaplan-Meier Kaplan-Meier analysis Lopinavir maintain management monotherapy non-inferiority non-inferiority margin non-inferiority trial number once daily Open-label parallel-group participant positive Pragmatic preserved Primary outcome Probability Protease inhibitor protease inhibitors public sector randomisation randomisation list randomised Randomly rebound Registered Ritonavir Serious Adverse Events shown Standard stratified suppressed the patient therapy toxic effects Treatment treatment failure Trial Viral Viral load virus [DOI] 10.1016/S2352-3018(15)00176-9 PMC 바로가기 [Article Type] Articles
Modeling 3D Facial Shape from DNADNA에서 3D 얼굴 모양 모델링Research Article Published on 2014-03-202022-09-06 Journal: PLoS Genetics [Category] Communicable Disease, [키워드] addition affecting African age allele ancestors ancestry appearance approach Brazil BRIM Cape complex Culture cultures Deceased descendants diagnostic DNA Effect European example eyes facial feature femininity foundation Genes Genetic markers genomic Genotype Health help Human human body identify in addition to independent Intention modeling nose philtrum pool populations predict predicted Predictive provide Result RIP Sex shape significant effect spacing strength subject subset Support tested United States variable variables Variation West width [DOI] 10.1371/journal.pgen.1004224 PMC 바로가기 [Article Type] Research Article